The company’s lead product, VYKAT™ XR (diazoxide choline) extended-release, is a once-daily oral treatment for hyperphagia in individuals aged 4 and older who have Prader-Willi syndrome (PWS).
The company’s lead product, VYKAT™ XR (diazoxide choline) extended-release, is a once-daily oral treatment for hyperphagia in individuals aged 4 and older who have Prader-Willi syndrome (PWS).